BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fasano RM, Leong T, Kaushal M, Sagiv E, Luban NL, Meier ER. Effectiveness of red blood cell exchange, partial manual exchange, and simple transfusion concurrently with iron chelation therapy in reducing iron overload in chronically transfused sickle cell anemia patients. Transfusion 2016;56:1707-15. [PMID: 26997031 DOI: 10.1111/trf.13558] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Mukherjee S, Sahu A, Ray GK, Maiti R, Prakash S. Comparative evaluation of efficacy and safety of automated versus manual red cell exchange in sickle cell disease: A systematic review and meta‐analysis. Vox Sanguinis. [DOI: 10.1111/vox.13288] [Reference Citation Analysis]
2 Wade J, Yee MEM, Easley KA, Pahz S, Butler H, Zerra PE, Josephson CD, Fasano RM. Procedural adverse events in pediatric patients with sickle cell disease undergoing chronic automated red cell exchange. Transfusion 2022. [PMID: 35072269 DOI: 10.1111/trf.16807] [Reference Citation Analysis]
3 Han H, Hensch L, Tubman VN. Indications for transfusion in the management of sickle cell disease. Hematology Am Soc Hematol Educ Program 2021;2021:696-703. [PMID: 34889416 DOI: 10.1182/hematology.2021000307] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Ha AS, Wallace BK, Miles C, Raup V, Punjani N, Badalato GM, Alukal JP. Exploring the Use of Exchange Transfusion in the Surgical Management of Priapism in Sickle Cell Disease: A Population-Based Analysis. J Sex Med 2021;18:1788-96. [PMID: 34600645 DOI: 10.1016/j.jsxm.2021.07.006] [Reference Citation Analysis]
5 Wilson SR, Sears M, Williams E, Drapekin J, Sivakumar I, Padrino S, Desai PC, Hager W, Manwani D, Clay LJ, Field JJ, Kanter J, Cohen AJ, Saif Ur Rehman S, Lanzkron S, Little JA; GRNDaD investigators. Gaps in the diagnosis and management of iron overload in sickle cell disease: a 'real-world' report from the GRNDaD registry. Br J Haematol 2021. [PMID: 34423416 DOI: 10.1111/bjh.17762] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Linder GE, Chou ST. Red cell transfusion and alloimmunization in sickle cell disease. Haematologica 2021;106:1805-15. [PMID: 33792218 DOI: 10.3324/haematol.2020.270546] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
7 Diop S, Pirenne F. Transfusion and sickle cell anemia in Africa. Transfusion Clinique et Biologique 2021;28:143-5. [DOI: 10.1016/j.tracli.2021.01.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Ait Abdallah N, Connes P, Di Liberto G, Offredo L, Beaumont JL, Menouche D, Debbache K, Jebali A, Habibi A, Pirenne F, Galacteros F, Ranque B, Bartolucci P. Automated RBC Exchange has a greater effect on whole blood viscosity than manual whole blood exchange in adult patients with sickle cell disease. Vox Sang 2020;115:722-8. [DOI: 10.1111/vox.12990] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Chou ST, Alsawas M, Fasano RM, Field JJ, Hendrickson JE, Howard J, Kameka M, Kwiatkowski JL, Pirenne F, Shi PA, Stowell SR, Thein SL, Westhoff CM, Wong TE, Akl EA. American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support. Blood Adv 2020;4:327-55. [PMID: 31985807 DOI: 10.1182/bloodadvances.2019001143] [Cited by in Crossref: 54] [Cited by in F6Publishing: 101] [Article Influence: 27.0] [Reference Citation Analysis]
10 Ardalan ZS, Chandran S, Vasudevan A, Angus PW, Grigg A, He S, Macdonald GA, Strasser SI, Tate CJ, Kennedy GA, Testro AG, Gow PJ. Management of Patients With Erythropoietic Protoporphyria-Related Progressive Liver Disease. Liver Transpl 2019;25:1620-33. [PMID: 31469227 DOI: 10.1002/lt.25632] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
11 Kamyszek RW, Raval JS, Srinivasan AJ, Ansari AK, Evans BA, Rollins‐raval MA, Poisson JL, Shah NR, Welsby IJ. Interval decline in hemoglobin A is associated with annual clinical event rate in sickle cell anemia patients receiving maintenance apheresis RBC exchange. Transfusion 2019;59:2622-8. [DOI: 10.1111/trf.15386] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
12 Fort R. Recommendations for the use of red blood cell exchange in sickle cell disease. Transfus Apher Sci 2019;58:128-31. [PMID: 30879904 DOI: 10.1016/j.transci.2019.03.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
13 Hequet O, Poutrel S, Connes P, Revesz D, Chelghoum Y, Kebaili K, Cannas G, Gauthier A, Guironnet-Paquet A, Vocanson M, Nicolas JF, Renoux C, Raba M, Cognasse F, Bertrand Y, Hot A, Joly P. Automatic depletion with Spectra Optia allows a safe 16% reduction of red blood cell pack consumption in exchanged sickle cell anemia patients. Transfusion 2019;59:1692-7. [PMID: 30747440 DOI: 10.1111/trf.15188] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
14 Fasano RM, Branscomb J, Lane PA, Josephson CD, Snyder AB, Eckman JR. Transfusion service knowledge and immunohaematological practices related to sickle cell disease and thalassemia. Transfus Med 2019;29:185-92. [PMID: 30740798 DOI: 10.1111/tme.12580] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
15 Fasano RM, Meyer EK, Branscomb J, White MS, Gibson RW, Eckman JR. Impact of Red Blood Cell Antigen Matching on Alloimmunization and Transfusion Complications in Patients with Sickle Cell Disease: A Systematic Review. Transfusion Medicine Reviews 2019;33:12-23. [DOI: 10.1016/j.tmrv.2018.07.003] [Cited by in Crossref: 17] [Cited by in F6Publishing: 25] [Article Influence: 5.7] [Reference Citation Analysis]
16 Meier ER. Treatment Options for Sickle Cell Disease. Pediatr Clin North Am 2018;65:427-43. [PMID: 29803275 DOI: 10.1016/j.pcl.2018.01.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
17 Thein SL, Howard J. How I treat the older adult with sickle cell disease. Blood 2018;132:1750-60. [PMID: 30206116 DOI: 10.1182/blood-2018-03-818161] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
18 Willits I, Cole H, Jones R, Carter K, Arber M, Jenks M, Craig J, Sims A. Spectra Optia® for Automated Red Blood Cell Exchange in Patients with Sickle Cell Disease: A NICE Medical Technology Guidance. Appl Health Econ Health Policy 2017;15:455-68. [PMID: 28110486 DOI: 10.1007/s40258-016-0302-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
19 Hulbert ML, Shenoy S. Hematopoietic stem cell transplantation for sickle cell disease: Progress and challenges. Pediatr Blood Cancer 2018;65:e27263. [PMID: 29797658 DOI: 10.1002/pbc.27263] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
20 Yee MEM, Josephson CD, Winkler AM, Webb J, Luban NLC, Leong T, Stowell SR, Roback JD, Fasano RM. Hemoglobin A clearance in children with sickle cell anemia on chronic transfusion therapy. Transfusion 2018;58:1363-71. [PMID: 29664198 DOI: 10.1111/trf.14610] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
21 Otrock ZK, Thibodeaux SR, Jackups R. Vascular access for red blood cell exchange: Vascular Access for RBC Exchange. Transfusion 2018;58:569-79. [DOI: 10.1111/trf.14495] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
22 Allali S, de Montalembert M, Brousse V, Chalumeau M, Karim Z. Management of iron overload in hemoglobinopathies. Transfus Clin Biol 2017;24:223-6. [PMID: 28673501 DOI: 10.1016/j.tracli.2017.06.008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
23 Woods D, Hayashi RJ, Binkley MM, Sparks GW, Hulbert ML. Increased complications of chronic erythrocytapheresis compared with manual exchange transfusions in children and adolescents with sickle cell disease. Pediatr Blood Cancer 2017;64:e26635. [DOI: 10.1002/pbc.26635] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
24 Howard J. Sickle cell disease: when and how to transfuse. Hematology Am Soc Hematol Educ Program 2016;2016:625-31. [PMID: 27913538 DOI: 10.1182/asheducation-2016.1.625] [Cited by in Crossref: 46] [Cited by in F6Publishing: 51] [Article Influence: 9.2] [Reference Citation Analysis]
25 Coates TD, Wood JC. How we manage iron overload in sickle cell patients. Br J Haematol 2017;177:703-16. [PMID: 28295188 DOI: 10.1111/bjh.14575] [Cited by in Crossref: 32] [Cited by in F6Publishing: 37] [Article Influence: 6.4] [Reference Citation Analysis]
26 de Montalembert M, Ribeil JA, Brousse V, Guerci-Bresler A, Stamatoullas A, Vannier JP, Dumesnil C, Lahary A, Touati M, Bouabdallah K, Cavazzana M, Chauzit E, Baptiste A, Lefebvre T, Puy H, Elie C, Karim Z, Ernst O, Rose C. Cardiac iron overload in chronically transfused patients with thalassemia, sickle cell anemia, or myelodysplastic syndrome. PLoS One 2017;12:e0172147. [PMID: 28257476 DOI: 10.1371/journal.pone.0172147] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 6.2] [Reference Citation Analysis]
27 Quillen K. The trials and tribulations of chronic transfusion in pediatric sickle cell disease: progress from STOP to TWiTCH? Transfusion 2016;56:1673-4. [PMID: 27389991 DOI: 10.1111/trf.13662] [Reference Citation Analysis]